PMI(PM)

Search documents
Can ZYN and IQOS Sustain Philip Morris' Smoke-Free Surge?
ZACKS· 2025-07-31 16:21
Core Insights - Philip Morris International's smoke-free business is expanding significantly, with IQOS and ZYN being pivotal to this growth. In Q2 2025, smoke-free business contributed 41% of total net revenues and over 42% of total gross profit, indicating a strong shift from combustible products [1][8]. Smoke-Free Business Performance - Smoke-free business net revenues increased by 15.2% year-over-year (14.5% organically), while gross profit rose by 23.3% (21.5% organically), outpacing the growth of combustible products [1]. - IQOS, the heat-not-burn device, experienced an 11.4% increase in global sales in Q2, with a market share of 31.7% in Japan and a rise of 1.2 points to 10.9% in Europe [2][8]. - ZYN, the leading nicotine pouch, saw a 36% growth in June and 26% in Q2 in the U.S., with global shipments increasing by 43% year-over-year, driven by strong U.S. demand and international expansion [3][8]. Competitive Landscape - Altria Group's on! nicotine pouch brand reported a 26.5% increase in shipments to 52.1 million cans in Q2 2025, capturing an 8.7% retail share of the U.S. oral tobacco market [5]. - Turning Point Brands' modern oral nicotine pouch sales surged nearly tenfold year-over-year, generating $22.3 million in revenues, with a revised full-year sales guidance of $80–$95 million [6]. Valuation and Earnings Estimates - Philip Morris shares have declined by 8.6% in the past month, compared to a 1.7% decline in the industry [7]. - The company trades at a forward price-to-earnings ratio of 20.26X, higher than the industry's average of 14.56X [10]. - Zacks Consensus Estimates indicate year-over-year earnings growth of 14% for 2025 and 12% for 2026 [11].
MO vs. PM: Which Tobacco Stock Has More Puff Left in 2025?
ZACKS· 2025-07-28 17:40
Core Insights - The tobacco sector presents two main investment options: Altria Group, Inc. and Philip Morris International Inc., each with distinct market strategies and growth trajectories towards a smoke-free future [1][2] Altria Group, Inc. - Altria focuses on the U.S. market, leveraging its Marlboro brand while expanding into alternatives like NJOY and oral nicotine pouches [2] - The company achieved a 10.8% net price realization in smokeable products in Q1 2025, contributing to a 2.7% increase in adjusted operating income [3][9] - Altria's oral nicotine pouch brand, on!, saw an 18% increase in shipments, capturing 8.8% of the oral tobacco category and 17.9% of the nicotine pouch segment [4][9] - Despite setbacks in the e-vapor category, Altria is refining its product pipeline and advocating for regulatory reforms to combat the rise of illicit disposable e-vapor products, which account for over 60% of the U.S. market [5] - The cigarette industry faces challenges, with shipment volumes declining due to macroeconomic pressures and the growth of illegal e-vapor products, impacting low-income smokers [6] Philip Morris International Inc. - Philip Morris is advancing its transformation strategy with a strong smoke-free portfolio, including IQOS, ZYN, and VEEV, and has approximately 41.5 million adult users by Q2 2025 [7][9] - IQOS is the primary driver of growth, with accelerated adoption in key markets supported by commercial initiatives and product innovations [8][10] - The company offers smoke-free products in 97 markets, with nearly half providing multiple product categories, enhancing its global reach [10] - Philip Morris faces challenges such as currency volatility and increasing regulatory risks, particularly regarding nicotine pouch marketing [11] Financial Performance and Valuation - Altria's forward P/E ratio is 10.96, appealing to income-focused investors, while Philip Morris has a higher multiple of 20.12, reflecting its global presence and momentum in smoke-free products [15] - Over the past month, Altria gained 2.1%, while Philip Morris dropped 11.6%, underperforming the S&P 500's 3.4% rise [14] Conclusion - Philip Morris is better positioned for long-term growth with its aggressive pivot towards a smoke-free future and strong global traction, while Altria's focus on domestic stability and pricing strength supports income-focused investors but faces more headwinds [16]
PMI对HNB全年销量预期不变,把握新型烟草产业链布局机遇
SINOLINK SECURITIES· 2025-07-28 14:11
Investment Rating - The industry is rated as "Buy" based on the expectation of an increase exceeding 15% in the next 3-6 months [6] Core Insights - The new tobacco industry continues to show strong growth trends, with PMI reporting a revenue increase of 7.1% and adjusted operating profit growth of 16.1% in Q2 2025 [1] - The HNB (Heated Not Burned) market is expected to grow significantly, particularly in the U.S., as the FDA's approval of JUUL products indicates a clear trend towards market expansion [2][3] - The overall HNB global market is on a continuous growth trajectory, with the U.S. market poised to contribute significantly to this growth [4] Summary by Sections Financial Performance - In Q2 2025, PMI achieved revenues of $10.1 billion and adjusted operating profits of $4.3 billion, reflecting year-on-year increases of 7.1% and 16.1% respectively [1] - New tobacco revenue in Q2 2025 reached $4.2 billion, a 15.2% increase year-on-year, with HNB sales volume also increasing by 9.2% to 38.8 billion sticks [1] Regulatory Environment - The FDA has approved JUUL's products for sale in the U.S., increasing the total number of approved vaping products from 34 to 39, indicating a more favorable regulatory environment for compliant products [2] - The FDA's focus on combating illegal products while facilitating the approval of compliant products suggests a dual approach to market regulation [3] Market Outlook - The HNB market in Europe is recovering from flavor bans, with PMI reporting double-digit growth in Q2 2025, indicating resilience in consumer demand [3] - The legal market for HNB products is expected to expand significantly, driven by regulatory changes and increasing consumer acceptance [4]
重视中烟香港获“长城”雪茄独家经销权,舆论或催化个护线上格局优化
SINOLINK SECURITIES· 2025-07-27 13:24
Investment Rating - The report provides a positive outlook on various sectors, indicating a stable recovery in the home furnishing and paper packaging sectors, while new tobacco and packaging sectors show robust growth [3][4]. Core Insights - The home furnishing sector is expected to see marginal improvement in domestic demand due to government support for consumption upgrades, with a focus on companies with high dividend yields and growth certainty for 2025 [5][10]. - The new tobacco sector is experiencing growth, particularly in heated tobacco products (HTP), with significant sales increases reported in Europe and a growing user base for IQOS [11]. - The paper packaging sector is facing a gradual recovery in pulp prices, with a focus on companies that maintain strong market positions and high dividends [12]. - The light consumer goods and pet food sectors are under pressure, but there are opportunities in innovative product launches and channel expansion [15]. - The two-wheeler sector is poised for a rebound with government subsidies and new standards expected to drive demand [16][17]. Summary by Sections Home Furnishing - Domestic sales are expected to improve due to government initiatives, with a focus on companies with strong growth prospects and high dividends [5][10]. - Export figures show a slight increase in June, but a cumulative decline for the first half of the year [10]. New Tobacco - HNB sales increased by 10.5% year-on-year, with a growing user base for IQOS [11]. - The regulatory environment in the U.S. is tightening, which may benefit compliant market players [11]. Paper Packaging - Pulp prices have shown slight increases, but overall market conditions remain challenging [12]. - Companies with strong market positions and dividend policies are recommended for investment [12]. Light Consumer Goods & Pet Food - The sector is facing challenges, but there are opportunities in new product launches and expanding distribution channels [15]. - Online sales data indicates mixed performance across different product categories [23]. Two-Wheeler - The sector is expected to benefit from government subsidies and new regulations, with a focus on companies that can leverage these changes for growth [16][17]. - Recent data shows a significant number of electric bikes being replaced under the subsidy program [26][27].
Philip Morris International Shares Tumble: Time to Run for the Hills or Buy the Dip?
The Motley Fool· 2025-07-27 08:50
Core Viewpoint - Traditional cigarette sales are declining, but Philip Morris International is offsetting this with strong growth in its newer nicotine products, particularly the Zyn brand and heated tobacco units [1][10]. Group 1: Sales Performance - Zyn shipments in the U.S. increased by 40% to 190 million cans in Q2, with retail sales volumes growing by 26% in the quarter and 36% in June [1]. - Outside the U.S. and Nordic countries, Zyn shipments more than doubled, now available in 44 markets, with overall oral product shipments climbing 23.8% [2]. - Sales volumes of heated tobacco units (HTUs), including the Iqos system, rose nearly 9.2% to 38.8 billion units, with in-market sales increasing by 11.4% [4]. - E-vapor product Veev saw shipment growth more than double, driven by pod growth in Europe, now in 42 markets and holding the No. 1 market share in six European markets [5]. Group 2: Financial Metrics - Organic revenue rose 6.8% year over year to $10.1 billion, with adjusted earnings per share (EPS) climbing 20% to $1.91 [6]. - Traditional cigarette volumes fell by 1.5% to 155.2 billion units, but segment organic revenue grew 2% to $6 billion, and gross profits increased by 5% to $4 billion due to price hikes [5]. - Management maintained its full-year guidance for organic revenue growth at 6% to 8% while raising adjusted EPS guidance to $7.43 to $7.56 [9]. Group 3: Market Outlook - The company expects a 3% to 4% decline in traditional cigarette volumes due to supply chain issues in Turkey and competition from illicit cigarettes in Indonesia [7][8]. - Despite the forecast for steeper declines in cigarette sales volumes, the smoke-free portfolio, particularly Zyn and Iqos, continues to show strong growth and better unit economics [10][11]. - The stock is viewed as undervalued with a forward price-to-earnings (P/E) ratio under 22 and a PEG ratio below 0.35, indicating potential for growth [12]. Group 4: Investment Considerations - The current share price offers a forward dividend yield of 3.3%, which, while lower than some competitors, positions the company as a unique growth stock in a defensive industry [13]. - The dip in stock price presents a potential buying opportunity for long-term investors [13].
Here's Why Philip Morris Raises Its 2025 EPS Guidance Again
ZACKS· 2025-07-25 15:56
Core Insights - Philip Morris International (PM) raised its 2025 earnings per share (EPS) guidance to $7.43-$7.56, reflecting strong second-quarter performance driven by smoke-free products, indicating a year-over-year growth of 13-15% [1][10] Financial Performance - In Q2 2025, smoke-free net revenues increased by 15.2% year over year, with gross profit for this segment rising over 23%, contributing 41% to total net revenues and 42% to gross profit [2][10] - Adjusted operating income grew by 16.1% in the quarter, outpacing revenue gains, attributed to strong pricing, improved scale efficiencies, and a favorable category mix towards higher-margin smoke-free products [4][10] Product Performance - The multi-category smoke-free platform showed broad-based growth, with IQOS heated tobacco units' adjusted in-market sales rising by 11.4%, supported by global expansion and recovery in European markets [3] - ZYN experienced a significant rebound, with U.S. consumer offtake increasing by 26% in the quarter and 36% in June, driven by better in-store availability and renewed commercial activity [3] Market Strategy - The raised EPS guidance indicates management's confidence in the sustainability of recent smoke-free category growth, suggesting that the multi-category strategy is gaining traction faster than anticipated [5] Competitive Landscape - Altria Group's "on!" nicotine pouch brand saw an 18% increase in shipment volume, while Turning Point Brands reported nearly tenfold growth in modern oral nicotine pouch sales, contributing $22.3 million in revenues [6][7][8] Valuation Metrics - Philip Morris shares have declined by 10.2% in the past month, compared to the industry's decline of 2.2% [9] - The company trades at a forward price-to-earnings ratio of 20.16X, higher than the industry's average of 14.67X [12] - The Zacks Consensus Estimate for PM's earnings implies year-over-year growth of 14.2% for 2025 and 11.9% for 2026 [13]
Philip Morris Smoke-Free Revenue at 41%
The Motley Fool· 2025-07-25 12:35
Company Overview and Strategic Direction - Philip Morris International is a leading global producer of tobacco and nicotine products, operating in approximately 170 markets with well-known brands such as Marlboro, Parliament, IQOS, ZYN, and VEEV [2] - The company is transitioning from traditional combustible cigarettes to smoke-free alternatives, including heated tobacco devices, oral nicotine pouches, and electronic vapor products [3] Quarterly Performance Highlights - In Q2 2025, adjusted earnings per share were $1.91, exceeding the estimate of $1.86 by 2.7%, while GAAP revenue was $10.1 billion, falling short by 2.1% [1] - Smoke-free products accounted for 41% of net revenue, an increase of 2.9 percentage points year-over-year, with gross profit from these products exceeding 42% of total gross profit [4] - Shipments of smoke-free products rose by 11.8%, with net revenue in this segment increasing by 15.2% and gross profit up by 23.3% [4] Product Performance - IQOS generated over $3 billion in net revenue, holding a 76% share of the global heat-not-burn category, with sales volumes in Europe growing by 9.1% and in Japan by 7.8% [5] - ZYN pouches saw a global shipment volume increase of 26.5%, with U.S. shipments rising over 40% to 190 million cans [6] - VEEV e-vapor product volumes more than doubled, achieving top market positions in six European countries [6] Traditional Cigarette Segment - Traditional cigarette volumes declined by 1.5%, but revenue for this segment grew by 2.1% due to strong pricing [7] - Marketing, Administration, and Research Costs increased by 16.0% compared to the previous year [7] Regional Performance - Europe's organic revenue rose by 7.3%, driven by smoke-free growth, while the Americas experienced a 17% increase in organic net revenues, primarily from oral nicotine [8] - The European market faced a 1.7% decline in shipment volume, mainly due to cigarette declines in specific countries [8] Future Outlook - The company raised its full-year adjusted diluted EPS guidance to $7.43, reflecting an 11.5% to 13.5% growth from last year's adjusted EPS of $6.57 [10] - Organic net revenue growth is forecasted at 6-8%, with smoke-free product volumes expected to grow by 12-14% and cigarette volumes projected to decline by about 2% [10] - Capital expenditure guidance is set at $1.6 billion, primarily for smoke-free product scale-up, with operating cash flow expected around $11.5 billion [10]
PMI(PM) - 2025 Q2 - Quarterly Report
2025-07-25 12:11
(Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-33708 Philip Morris International Inc. | (Exact name of registrant as specified in its charter) | | | | | --- | ...
Philip Morris (PM) Loses 10.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ZACKS· 2025-07-23 14:36
Core Viewpoint - Philip Morris (PM) is experiencing significant selling pressure, with a 10.4% decline over the past four weeks, but is now positioned for a potential trend reversal as it enters oversold territory, supported by analyst expectations of better-than-previously predicted earnings [1]. Group 1: Technical Indicators - The Relative Strength Index (RSI) is a key technical indicator used to identify oversold conditions, with a reading below 30 typically indicating that a stock is oversold [2]. - PM's current RSI reading is 27.52, suggesting that the heavy selling may be exhausting itself, indicating a potential bounce back towards equilibrium in supply and demand [5]. - The RSI helps investors identify entry opportunities when a stock is undervalued due to unwarranted selling pressure [3]. Group 2: Fundamental Indicators - There is a strong consensus among sell-side analysts that PM will report better earnings, leading to a 0.5% increase in the consensus EPS estimate over the last 30 days [7]. - An upward trend in earnings estimate revisions is typically associated with price appreciation in the near term, further supporting the potential for a rebound in PM's stock price [7]. - PM holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate trends and EPS surprises, indicating a strong potential for a turnaround [8].
X @Investopedia
Investopedia· 2025-07-22 23:00
Philip Morris International shares sank Tuesday after the tobacco giant missed quarterly sales estimates as demand for cigarettes continued to decline. https://t.co/jxUXPWbJ2K ...